FDA Inspection
Altasciences Preclinical Seattle, LLCAltasciences Preclinical Seattle, LLC – FDA Inspection, Sep 13, 2019
Record Details
This FDA Inspection record concerns Altasciences Preclinical Seattle, LLC, with an inspection on September 13, 2019, issued by the Seattle District Office, covering human drugs.
- Inspection Date
- September 13, 2019
- Product Type
- Human Drugs
- Office
- Seattle District Office
- People
- Hugh M. Mcclure (Issuing Officer)
- Julian C. Hanson (Issuing Officer)
- Mark J. Seaton (Company Rep)
View Company Profile
ID · a7dbd1bc-fd64-4299-b9b3-defd7e208fe7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1101843
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 58.33(c)Study director: unforeseen circumstances
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Altasciences Preclinical Seattle, LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| July 18, 2025 | VAI | Seattle District Office | Bioresearch Monitoring: Human Drugs |
| July 14, 2023 | VAI | Seattle District Office |
Other documents for Altasciences Preclinical Seattle, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.